Biogen Inc. (BIIB)
Biogen Inc. reported revenue of $9.89B for the fiscal year ended Dec 31, 2025, up 2.2% from $9.68B the year before. Net income was $1.29B, a net margin of 13.1% (prior year: $1.63B). At the end of that fiscal year the company reported total assets of $29.44B and shareholders' equity of $18.26B.
Revenue
$9.89B
+2.2% vs prior year
Net income
$1.29B
Net margin 13.1%
Diluted EPS
$8.79
USD per share
Total assets
$29.44B
At Dec 31, 2025
Equity
$18.26B
At Dec 31, 2025
Shares outstanding
148M
As of Oct 26, 2026
Explore Biogen Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 28, 2026
- 10-QFiled Jul 29, 2026
- 10-QFiled Apr 29, 2026
- 10-KFiled Feb 6, 2026
- 10-QFiled Oct 30, 2025
- 10-QFiled Jul 31, 2025
Source: SEC EDGAR XBRL company facts for CIK 875045 (raw data). Most recent filing in this dataset: 10-Q filed Oct 28, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.